Related by context. Frequent words. (Click for all words.) 60 Preclinical Development 60 Pepscan 60 GSK Oncology 59 Paul Stoffels 59 Taashi Rowe editorial 58 EMD Millipore 58 Moncef Slaoui 57 Nobilon 57 NITD 57 Selcia 57 Immunex Corporation 56 Ortho Biotech Oncology 56 ClinTec International 56 Lankenau Institute 56 GSK Biologicals 56 Anti Infective 56 Shoulders R 56 Inflammatory Diseases 56 Therapeutic Competitors Report 56 Neck Oncology 56 Ecron Acunova 55 Exploit collaboration 55 By Katie Klingsporn 55 Maven Semantic 55 Daryl Copeland Adjunct 55 Boehringer Mannheim 55 Metabolic Disease 55 Flow Cytometry 55 Metabolic Disorders 55 OSUCCC James 55 Immune Tolerance Network 55 Regulatory Disclosure 55 Nitec 55 Molecular Virology 55 Professor Eldad Melamed 55 Immunobiology 55 Drug Shows Promise 55 By Traian Teglet 54 GVK Biosciences 54 By HARVEY SIMPSON 54 By Marius Oiaga 54 By Rick Nauert 54 By KRISTEN SENZ 54 Proprietary Products 54 Develop Novel 54 By Tudor Vieru 54 Biopharmaceutical Industry 54 Biological Therapy 53 oncolytic virus therapies 53 Helmholtz Zentrum München 53 #:#-#,# CrossRef Medline [002] 53 immuno inflammatory diseases 53 Marc Cluzel 53 Metabolic Diseases 53 Hubert Yoshida vice 53 Harpo Studios produces 53 Steve Berberich 52 RNAi Therapeutics 52 oncology immunology 52 Dotmatics 52 Xceleron 52 Ophthalmics 52 & Grow Faster 52 Novartis Ophthalmics 52 By Jeremy Laurance 52 Inc Therapeutic Competitors 52 Hired Brains 52 Meets Primary Endpoint 52 Sackler Institute 52 fibrosis IPF 52 Molecular Diagnostic 52 Small Molecule 51 Tracey Schelmetic 51 Novel Therapies 51 Monoclonal Antibody 51 immunologic diseases 51 Innovative Medicines 51 Fresenius Kabi AG 51 % #F# 4v.jsn 51 Hemostasis 51 Wyeth Vaccines 51 Diabetes Endocrinology 51 Endocrinol 50 Burt Adelman 50 Pressure BioSciences 50 Comment FAQ 50 Pipeline Analysis 50 Intendis 50 Maternity Cover 50 ophthalmics 50 Gastroenterology Hepatology 50 Monoclonal Antibodies 50 Initiates Phase II 50 Genome BC 50 Breast Oncology 50 Genetic Disease 50 Lee Byeong chun 50 VIDO 50 Specialized Therapeutics 50 Investor Relations tel 50 Jay Keasling